These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37573820)
1. [Vaccination against the herpes zoster virus]. Gómez Marco JJ; Martín Martín S; Aldaz Herce P; Javierre Miranda AP; Sánchez Hernández C Aten Primaria; 2023 Oct; 55(10):102710. PubMed ID: 37573820 [TBL] [Abstract][Full Text] [Related]
2. Vaccines for preventing herpes zoster in older adults. Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946 [TBL] [Abstract][Full Text] [Related]
3. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine. James SF; Chahine EB; Sucher AJ; Hanna C Ann Pharmacother; 2018 Jul; 52(7):673-680. PubMed ID: 29457489 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. Lal H; Poder A; Campora L; Geeraerts B; Oostvogels L; Vanden Abeele C; Heineman TC Vaccine; 2018 Jan; 36(1):148-154. PubMed ID: 29174683 [TBL] [Abstract][Full Text] [Related]
6. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials. López-Fauqued M; Co-van der Mee M; Bastidas A; Beukelaers P; Dagnew AF; Fernandez Garcia JJ; Schuind A; Tavares-da-Silva F Drug Saf; 2021 Jul; 44(7):811-823. PubMed ID: 34115324 [TBL] [Abstract][Full Text] [Related]
7. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations. Parikh R; Widenmaier R; Lecrenier N Expert Rev Vaccines; 2021 Sep; 20(9):1065-1075. PubMed ID: 34311643 [TBL] [Abstract][Full Text] [Related]
8. A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus. Bharucha T; Ming D; Breuer J Hum Vaccin Immunother; 2017 Aug; 13(8):1789-1797. PubMed ID: 28426274 [TBL] [Abstract][Full Text] [Related]
9. Shingrix for Herpes Zoster: A Review. Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine. Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany. Curran D; Van Oorschot D; Matthews S; Hain J; Salem AE; Schwarz M Hum Vaccin Immunother; 2021 Dec; 17(12):5296-5303. PubMed ID: 34905463 [TBL] [Abstract][Full Text] [Related]
12. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice. Stadtmauer EA; Sullivan KM; El Idrissi M; Salaun B; Alonso Alonso A; Andreadis C; Anttila VJ; Bloor AJ; Broady R; Cellini C; Cuneo A; Dagnew AF; Di Paolo E; Eom H; González-Rodríguez AP; Grigg A; Guenther A; Heineman TC; Jarque I; Kwak JY; Lucchesi A; Oostvogels L; Polo Zarzuela M; Schuind AE; Shea TC; Sinisalo UM; Vural F; Yáñez San Segundo L; Zachée P; Bastidas A Hum Vaccin Immunother; 2021 Nov; 17(11):4144-4154. PubMed ID: 34406911 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review. Giannelos N; Ng C; Curran D Hum Vaccin Immunother; 2023 Dec; 19(1):2168952. PubMed ID: 36916240 [TBL] [Abstract][Full Text] [Related]
15. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421 [TBL] [Abstract][Full Text] [Related]
16. [Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio]. Ferahta N; Achek I; Dubourg J; Lang PO Presse Med; 2016 Feb; 45(2):162-76. PubMed ID: 26724874 [TBL] [Abstract][Full Text] [Related]